Scientists unravel genetic secrets of bone marrow failure

NCT ID NCT07102849

First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 36 times

Summary

This study aims to understand the genetic and molecular changes in people with bone marrow failure disorders. Researchers will analyze blood and bone marrow samples from up to 1,400 participants to track how these changes evolve over time. The goal is to better predict disease outcomes and identify new targets for future treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • National Institutes of Health Clinical Center

    Bethesda, Maryland, 20892, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this research could reveal why some patients develop more serious blood cancers, pointing toward better monitoring or prevention strategies.

What could go wrong

This is an observational study, not a treatment trial. It may not directly lead to new therapies, and findings may not apply to all patients.

Conditions

The condition(s) this trial relates to.

aplastic anemia bone marrow disorder Bone Marrow Failure Disorders Hemoglobinuria, Paroxysmal Myelodysplastic Syndromes VEXAS syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.